Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5476 | 1619 | 40.9 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
365 | 3 | MICROTUBULES//MITOSIS//KINETOCHORE | 34118 |
2644 | 2 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 3490 |
5476 | 1 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 1619 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | COMBRETASTATIN | authKW | 2254507 | 8% | 87% | 137 |
2 | COMBRETASTATIN A 4 | authKW | 1644270 | 7% | 75% | 117 |
3 | VASCULAR DISRUPTING AGENTS | authKW | 1124946 | 6% | 59% | 101 |
4 | PHENSTATIN | authKW | 396037 | 1% | 100% | 21 |
5 | CANC TREATMENT DIAGFREDERICK CANC | address | 394091 | 2% | 65% | 32 |
6 | ZD6126 | authKW | 381880 | 2% | 75% | 27 |
7 | SCREENING TECHNOL BRANCH | address | 369410 | 4% | 29% | 68 |
8 | TUBULIN POLYMERIZATION | authKW | 328055 | 3% | 36% | 49 |
9 | COMBRETASTATIN A4 PHOSPHATE | authKW | 327976 | 1% | 87% | 20 |
10 | TUBULIN INHIBITOR | authKW | 315921 | 2% | 49% | 34 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 33321 | 42% | 0% | 686 |
2 | Oncology | 3905 | 27% | 0% | 430 |
3 | Chemistry, Organic | 2716 | 20% | 0% | 317 |
4 | Pharmacology & Pharmacy | 1593 | 20% | 0% | 327 |
5 | Biochemistry & Molecular Biology | 354 | 16% | 0% | 267 |
6 | Chemistry, Multidisciplinary | 81 | 8% | 0% | 126 |
7 | Radiology, Nuclear Medicine & Medical Imaging | 49 | 3% | 0% | 56 |
8 | Biochemical Research Methods | 7 | 2% | 0% | 28 |
9 | Crystallography | 3 | 1% | 0% | 17 |
10 | Cell Biology | 3 | 3% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC TREATMENT DIAGFREDERICK CANC | 394091 | 2% | 65% | 32 |
2 | SCREENING TECHNOL BRANCH | 369410 | 4% | 29% | 68 |
3 | CANC TREATMENT DIAGNIH | 221348 | 2% | 31% | 38 |
4 | DEV THER EUT PROGRAMNIH | 207900 | 1% | 53% | 21 |
5 | UNITE BIOTECHNOL BIOINGN | 134090 | 1% | 44% | 16 |
6 | ONCOEMATOL | 104789 | 1% | 33% | 17 |
7 | LP4 | 78577 | 0% | 83% | 5 |
8 | UNITA ONCOL SPERIMENTALE IMMUNOL | 75436 | 0% | 100% | 4 |
9 | TUMOR MICROCIRCULAT GRP | 67101 | 1% | 32% | 11 |
10 | GRAY CANC | 66034 | 2% | 12% | 29 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY | 21532 | 8% | 1% | 122 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 18388 | 9% | 1% | 145 |
3 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 13872 | 5% | 1% | 83 |
4 | CHEMMEDCHEM | 6410 | 2% | 1% | 28 |
5 | MEDCHEMCOMM | 6128 | 1% | 2% | 21 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 5693 | 5% | 0% | 88 |
7 | INVESTIGATIONAL NEW DRUGS | 4954 | 2% | 1% | 26 |
8 | ANTI-CANCER DRUG DESIGN | 2988 | 1% | 2% | 10 |
9 | LETTERS IN DRUG DESIGN & DISCOVERY | 2342 | 1% | 1% | 13 |
10 | CHEMICAL BIOLOGY & DRUG DESIGN | 2214 | 1% | 1% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMBRETASTATIN | 2254507 | 8% | 87% | 137 | Search COMBRETASTATIN | Search COMBRETASTATIN |
2 | COMBRETASTATIN A 4 | 1644270 | 7% | 75% | 117 | Search COMBRETASTATIN+A+4 | Search COMBRETASTATIN+A+4 |
3 | VASCULAR DISRUPTING AGENTS | 1124946 | 6% | 59% | 101 | Search VASCULAR+DISRUPTING+AGENTS | Search VASCULAR+DISRUPTING+AGENTS |
4 | PHENSTATIN | 396037 | 1% | 100% | 21 | Search PHENSTATIN | Search PHENSTATIN |
5 | ZD6126 | 381880 | 2% | 75% | 27 | Search ZD6126 | Search ZD6126 |
6 | TUBULIN POLYMERIZATION | 328055 | 3% | 36% | 49 | Search TUBULIN+POLYMERIZATION | Search TUBULIN+POLYMERIZATION |
7 | COMBRETASTATIN A4 PHOSPHATE | 327976 | 1% | 87% | 20 | Search COMBRETASTATIN+A4+PHOSPHATE | Search COMBRETASTATIN+A4+PHOSPHATE |
8 | TUBULIN INHIBITOR | 315921 | 2% | 49% | 34 | Search TUBULIN+INHIBITOR | Search TUBULIN+INHIBITOR |
9 | COLCHICINE BINDING SITE | 305511 | 1% | 90% | 18 | Search COLCHICINE+BINDING+SITE | Search COLCHICINE+BINDING+SITE |
10 | CA 4 | 286850 | 1% | 89% | 17 | Search CA+4 | Search CA+4 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GREENE, LM , MEEGAN, MJ , ZISTERER, DM , (2015) COMBRETASTATINS: MORE THAN JUST VASCULAR TARGETING AGENTS?.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 355. ISSUE 2. P. 212 -227 | 159 | 83% | 8 |
2 | PEREZ-PEREZ, MJ , PRIEGO, EM , BUENO, O , MARTINS, MS , CANELA, MD , LIEKENS, S , (2016) BLOCKING BLOOD FLOW TO SOLID TUMORS BY DESTABILIZING TUBULIN: AN APPROACH TO TARGETING TUMOR GROWTH.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 19. P. 8685 -8711 | 138 | 70% | 3 |
3 | RAJAK, H , DEWANGAN, PK , PATEL, V , JAIN, DK , SINGH, A , VEERASAMY, R , SHARMA, PC , DIXIT, A , (2013) DESIGN OF COMBRETASTATIN A-4 ANALOGS AS TUBULIN TARGETED VASCULAR DISRUPTING AGENT WITH SPECIAL EMPHASIS ON THEIR CIS-RESTRICTED ISOMERS.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 10. P. 1923-1955 | 111 | 78% | 18 |
4 | LU, Y , CHEN, JJ , XIAO, M , LI, W , MILLER, DD , (2012) AN OVERVIEW OF TUBULIN INHIBITORS THAT INTERACT WITH THE COLCHICINE BINDING SITE.PHARMACEUTICAL RESEARCH. VOL. 29. ISSUE 11. P. 2943 -2971 | 97 | 64% | 122 |
5 | TRON, GC , PIRALI, T , SORBA, G , PAGLIAI, F , BUSACCA, S , GENAZZANI, AA , (2006) MEDICINAL CHEMISTRY OF COMBRETASTATIN A4: PRESENT AND FUTURE DIRECTIONS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 49. ISSUE 11. P. 3033-3044 | 81 | 84% | 344 |
6 | PATIL, PO , PATIL, AG , RANE, RA , PATIL, PC , DESHMUKH, PK , BARI, SB , PATIL, DA , NAPHADE, SS , (2015) RECENT ADVANCEMENT IN DISCOVERY AND DEVELOPMENT OF NATURAL PRODUCT COMBRETASTATIN-INSPIRED ANTICANCER AGENTS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 8. P. 955 -969 | 81 | 94% | 5 |
7 | CHAUDHARY, A , PANDEYA, SN , KUMAR, P , SHARMA, P , GUPTA, S , SONI, N , VERMA, KK , BHARDWAJ, G , (2007) COMBRETASTATIN A-4 ANALOGS AS ANTICANCER AGENTS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 12. P. 1186-1205 | 97 | 88% | 80 |
8 | NAM, NH , (2003) COMBRETASTATIN A-4 ANALOGUES AS ANTIMITOTIC ANTITUMOR AGENTS.CURRENT MEDICINAL CHEMISTRY. VOL. 10. ISSUE 17. P. 1697-1722 | 98 | 76% | 232 |
9 | ALVAREZ, R , ARAMBURU, L , PUEBLA, P , CABALLERO, E , GONZALEZ, M , VICENTE, A , MEDARDE, M , PELAEZ, R , (2016) PYRIDINE BASED ANTITUMOUR COMPOUNDS ACTING AT THE COLCHICINE SITE.CURRENT MEDICINAL CHEMISTRY. VOL. 23. ISSUE 11. P. 1100 -1130 | 125 | 54% | 0 |
10 | MARRELLI, M , CONFORTI, F , STATTI, GA , CACHET, X , MICHEL, S , TILLEQUIN, F , MENICHINI, F , (2011) BIOLOGICAL POTENTIAL AND STRUCTURE-ACTIVITY RELATIONSHIPS OF MOST RECENTLY DEVELOPED VASCULAR DISRUPTING AGENTS: AN OVERVIEW OF NEW DERIVATIVES OF NATURAL COMBRETASTATIN A-4.CURRENT MEDICINAL CHEMISTRY. VOL. 18. ISSUE 20. P. 3035 -3081 | 76 | 83% | 39 |
Classes with closest relation at Level 1 |